The AI Revolution in Cancer Screening
Join us this October for a cutting-edge exploration of how Artificial Intelligence is impacting the landscape of modern breast cancer detection and prevention. This webinar will share updates on the PRISM study (the first large-scale US randomized controlled trial evaluating AI in breast cancer screening), pioneering research in Europe, and advances in risk assessment tools. Our speaker will also share updates in ovarian cancer screening research and equip you with actionable strategies to advocate for the most up-to-date, tech-forward care available.
Questions? Contact Danna Berg at [email protected].
